Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-LAG-3 Monoclonal Antibody BMS-986016

Known as: BMS-986016, BMS986016 
A monoclonal antibody directed against the inhibitor receptor lymphocyte activation gene-3 (LAG-3), with potential immunomodulating and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Immune checkpoint blockade using antibodies that target programmed-cell-death-1 (PD-1) or its ligand programmed-cell-death-ligand… Expand
Review
2018
Review
2018
Pancreatic ductal adenocarcinoma (PDA) is notoriously aggressive and hard to treat. The tumour microenvironment (TME) in PDA is… Expand
2018
2018
Lymphocyte Activation Gene-3 (LAG-3) is a soluble protein and transmembrane protein receptor expressed on lymphocytes such as… Expand
  • figure 2
  • table 1
  • figure 4
  • figure 6
  • figure 7
Highly Cited
2017
Highly Cited
2017
9520Background: Signaling via LAG-3 and other T-cell inhibitory receptors (eg, PD-1) can lead to T-cell dysfunction and tumor… Expand
Review
2017
Review
2017
Tumor cells can evade immune surveillance through overexpressing the ligands of checkpoint receptors on tumor cells or adjacent… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Highly Cited
2014
Highly Cited
2014
Chen, Lee, and colleagues compared the antitumor activity of anti-PD-1 in combination with anti-4-1BB versus with anti-LAG-3 and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5